Skip to main content
. Author manuscript; available in PMC: 2015 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):508–513. doi: 10.1097/QAI.0000000000000364

Table 1.

Demographic and clinical characteristics at the visit after HAART initiation (N = 1,313)

Site
     Baltimore 314(23.9)
     Chicago 311(23.7)
     Pittsburgh 295(22.5)
     Los Angeles 393(29.9)
Age, median (IQR), yrs 42.9(37.9–48.3)
Ethnicity, n (%)
     Caucasian 758(57.7)
     Hispanic/Latino 187(14.3)
     African American 348(26.5)
     Other Ethnic Minority 20(1.5)
Education, n (%)
     High School or Less 319(24.3)
     Some College 417(31.8)
     College Degree or Higher 577(43.9)
Ever Clinical AIDS Diagnosis, n (%) 175(13.3)
Pre-HAART CD4+ Cell Count (µl), median (IQR) 306(174–464)
     < 200 397(30.2)
     200 – 349 375(28.6)
     350 – 499 259(19.7)
     ≥ 500 282(21.5)
Log10HIV Viral Load, median (IQR) 3.5(1.6–4.6)
HCV-Positive, n (%) 137(10.4)
Body Mass Index, median (IQR) 24.4(22.5–27)
High Blood Pressure, n (%) 338(25.7)
Dyslipidemia, n (%) 566(43.1)
SF-36 Physical Component Summary, median (IQR) 52.3(42.9–56.1)
SF-36 Mental Component Summary, median (IQR) 51.0 (38.6–57.1)
CES-D ≥ 16, n (%) 408(31.1)
Binge Drinking, n (%) 120(9.1)
Smoking, n (%)
     Current 503(38.3)
     Past 470(35.8)
     Never 340(25.9)
Any Stimulant Use, n (%) 341(26)

HAART: highly active antiretroviral therapy. High Blood Pressure was defined if systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or diagnosed with hypertension and use of antihypertensive medications.

Dyslipidemia was defined if fasting total cholesterol ≥ 200 mg/dl or LDL ≥ 130 mg/dl or HDL < 40 mg/dl or triglycerides ≥ 150 mg/dl or use of lipid lowering medications with self-report of clinical diagnosis in the past.